Skip to main content

To: To the Department of Health & Social Care, Heath Secretary Sajid Javid, and MHRA (Medicines and Healthcare products Regulatory Agency)

Stop the clinically vulnerable from having to risk their lives to get the Covid drugs they need

Stop the clinically vulnerable from having to risk their lives to get the Covid drugs they need

Urgently license and distribute preventative treatments to protect those still clinically extremely vulnerable to COVID-19

Why is this important?

Today there are over 3 million people in the UK who are still clinically extremely vulnerable to Covid. Not only do our underlying health conditions put us at greater risk for severe disease or death, immunosuppression can cause the Covid vaccines to be less effective. Not all of us are mounting immune response to vaccinations, even after four doses, and as of October 2021, 91% of us were still shielding, nearly two years into this pandemic.

Right now the only protection the government is offering us is post-Covid infection: We are being asked to take our chances of getting the disease, which may be deadly for many of us, before we can access antivirals or monoclonals to help our chances of survival. We need a vaccine equivalent that protects us proactively so we can go back to living our lives safely. Without this, we live an isolated and perilous existence.

Some other countries have already approved monoclonal antibody treatments such as AstraZeneca's Evusheld as prevention against infection for the immunosuppressed community. We ask that these be fully approved, distributed and provided as long-term prophylaxis treatment to the clinically vulnerable in the UK.

Category

Updates

2022-03-17 11:51:36 +0000

We're very pleased to share that the MHRA has approved Evusheld as a prophylactic treatment for COVID-19. This treatment is for adults who are unlikely to mount an immune response from COVID-19 vaccination or for whom vaccination is not recommended.

We don't yet know when this treatment will be rolled out, the eligibility criteria or how people will be identified and invited for treatment, but this is definitely a positive step forward. We will update further as more information becomes available. Thank you to everyone who has supported this petition to date!

https://www.gov.uk/government/news/evusheld-approved-to-prevent-covid-19-in-people-whose-immune-response-is-poor

2022-02-16 13:31:58 +0000

1,000 signatures reached

2022-01-25 18:27:50 +0000

500 signatures reached

2022-01-24 09:31:32 +0000

100 signatures reached

2022-01-24 07:18:01 +0000

50 signatures reached

2022-01-23 23:19:13 +0000

25 signatures reached

2022-01-23 22:18:30 +0000

10 signatures reached